Psychologist Tom McLellan Testifies Before Senate Judiciary Committee

Tom McLellan, PhD, testified before the Senate Judiciary Committee during his nomination hearing to become the Deputy Director of the White House Office of National Drug Control Policy (ONDCP). Committee Members questioned him on issues related to the balance of supply and demand reduction activities at ONDCP, the regulation of medical marijuana and the value of drug courts.
On June 24, Tom McLellan, PhD, testified before the Senate Judiciary Committee during his nomination hearing to become the Deputy Director of the White House Office of National Drug Control Policy (ONDCP). Dr. McLellan answered questions from Committee Members on issues related to the balance of supply and demand reduction activities at ONDCP, the regulation of medical marijuana and the value of drug courts. Soon after his hearing, the focus of the Committee switched to Supreme Court nominee Sonya Sotomayor. In an effort to speed Dr. McLellan’s confirmation vote, Science GRO staff drafted a letter—endorsed by over 60 scientific, professional and provider groups—thanking the Committee for holding the hearing and urging an expedited confirmation vote. Dr. McLellan’s nomination was unanimously approved by the Committee on July 28. Although a final vote by the full Senate had not been scheduled as this issue of SPIN goes to press, it is very unusual for the full Senate to vote against a decision at the Committee level.